Related Experiment Video
Updated: May 29, 2025
07:49
Evaluation of Tumor-infiltrating Leukocyte Subsets in a Subcutaneous Tumor Model
Published on: April 13, 2015
20.0K
Tumor cells escape immunosurveillance by hampering LFA-1
Shishir Upadhyay1, Lewis Murugu1, Lena Svensson1,2
1Department of Molecular Biology, Umeå University, Umeå, Sweden.
Frontiers in Immunology
|February 6, 2025
Summary
Leukocyte function is vital for cancer immunosurveillance, with Lymphocyte Function-Associated Antigen 1 (LFA-1) mediating cell adhesion and activation. Tumors exploit LFA-1 to evade immune responses, necessitating targeted therapeutic strategies.
Area of Science:
- Immunology
- Cell Biology
- Oncology
Background:
- Leukocytes are key in tumor immunosurveillance, identifying and eliminating aberrant cells.
- Lymphocyte Function-Associated Antigen 1 (LFA-1) is critical for leukocyte adhesion, migration, and activation during immune responses.
- Tumors can evade immune detection by disrupting or hijacking LFA-1 pathways.
Purpose of the Study:
- To review the role of LFA-1 in leukocyte-mediated tumor immunosurveillance.
- To explore tumor evasion mechanisms involving LFA-1 in the tumor microenvironment (TME).
- To discuss LFA-1-targeting therapeutic strategies for cancer treatment.
Main Methods:
- Literature review of LFA-1 function in immunosurveillance.
- Analysis of tumor counter-mechanisms affecting LFA-1 in the TME.
- Review of preclinical and laboratory studies on LFA-1 inhibitors.
Main Results:
- LFA-1 facilitates essential leukocyte functions for anti-cancer immunity.
- Tumors manipulate LFA-1 to promote immune evasion and tumorigenesis.
- LFA-1 inhibitors show potential as anticancer agents in preclinical models.
Conclusions:
- Understanding LFA-1's dual role in cancer immunity and evasion is crucial.
- Targeting LFA-1 offers a promising therapeutic avenue for cancer intervention.
- Further clinical research is needed to validate LFA-1-based therapies.
Related Concept Videos
01:27Tumor Immunotherapy
464
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
464
02:17The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
02:30Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
01:35Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
02:40Cancer Stem Cells and Tumor Maintenance
4.7K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.7K
02:23Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K